March 19, 2010. Many people in the medical device industry claim that stricter standards for clearing or approving medical devices will stifle innovation.
Read More »On Health Policy
NCHR Testimony Regarding Senate Bill 1449 Bisphenol A-Free Children and Babies Act
February 1, 2011. Our Center strongly supports Senate Bill 1449, which will help to ensure that Virginia’s children are better protected from the adverse health effects of BPA.
Read More »Letter from the Patient, Consumer, and Public Health Coalition to FDA about Improving Medical Device Safety
January 18, 2011. We strongly believe that improving the standards needed to prove safety and effectiveness of medical devices will ensure that U.S. companies flourish and create jobs at the same time as they contribute to public health.
Read More »Patient, Consumer, and Public Health Coalition Letter to FDA Commissioner Expressing Concerns about FDA’s Policies and Practices Regarding FDA Advisory Committee Meetings
October 26, 2010. Advisory Committee meetings are a very important way for the FDA to show the public how they make decisions and value input from independent scientific experts and the public.
Read More »NCHR Comments to FDA on Medical Device User Fees (MDUFA)
November 1, 2010. A major concern is that the medical device user fees are too low to adequately support the Center for Devices and Radiological Health’s (CDRH) efforts to clear or approve safe and effective medical devices in a timely manner.
Read More »